“…International Journal of Rheumatic Diseases 2011;14;113-212. 3. Zhang Fu – Quang,Wu Ming – Xia, Liu Xian – Xiang, Gender and Sex distribution of middle and old aged people with osteoarthritis in Fuzhou, Vol II, May 2009. 4. …”
Enlace del recurso
Enlace del recurso

“…BACKGROUND: 5-Fluorouracil (5-FU) and capecitabine are fluoropyrimidine derivatives that mainly metabolized with dihydropyrimidine dehydrogenase enzyme (DPD). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The negative Tajima's D and Fu's Fs values of HCV-1b, 2a and 6a suggested the population expansion of those HCV subtypes. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CONCLUSIONS: Conversion factors can be integrated into the development of eHealth tools that are intended to be inclusive and contribute to curbing SHIs by integrating FU participation into the tool design process.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…All patients received two cycles of preoperative DCF therapy (60 mg/m(2) of docetaxel and cisplatin on day 1 and 700 mg/m(2)/day of 5-FU on days 1–5 in each cycle) followed by radical TME. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Samples were prospectively collected from patients (N = 132) who were treated with capecitabine or 5‐FU/LV with oxaliplatin ± bevacizumab. Response evaluation was performed according to RECIST 1.1 after three or four cycles, respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Relevant perioperative data, including 30-day mortality and neurological complications, were retrospectively obtained from our electronic patient’s records, including follow-up (FU) data of outpatient clinical visits and computed tomography (CT). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The AI+RT regimen consisted of one-shot intraarterial chemotherapy (AI) at the first angiography session, almost 6 months of reservoir AI (5-FU and cisplatin, q/week) and external radiation with a maximum dose of 50.6 Gy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Additionally, the increased ATG12 expression was more likely to get a satisfactory OS in patients who underwent surgery alone but was associated with poor OS for patients treated with 5-FU adjuvant. In addition, elevated TECPR1 expression was related to favorable OS for patients with poorly differentiated type, while for patients with moderate differentiation, it was relevant to poor OS. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Patients with colorectal cancer (CRC) treated with curative intent surgery undergo continuous fluorouracil (5-FU) infusion-based chemotherapy using totally implantable central venous port system (TICVPS) in cases with high risk of recurrence. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Several signaling pathways (TNF, mTOR, Hippo, neutrophin, and pathways regulating pluripotency of stem cells), transcription factors (RUNX1, FOXA1, HIF1A, and MYC), and small molecule drugs (curcumin, docosahexaenoic acid (DHA), vitamin D3, arsenic trioxide, 5-fluorouracil (5-FU), and naringin) were identified as common regulators of both the DPSC and BMSC osteodifferentiation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Transfected cell lines or patient-derived organoids (PDO) were treated with 5-fluorouracil (5-FU) and 6-mercaptopurine (6-MP) and drug response was correlated with ADSL expression levels. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Patients received radiotherapy with concurrent 5-Fluororuracil (5-FU)/Capecitabine and Oxaliplatin, and RHT. Stage 1 feasibility analysis evaluated dose-limiting toxicities (DLT) after 19 patients, stage 2 after 59 evaluable patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The proteomic analysis of purified EVs from SYO-1, HS-SY-II, and YaFuSS identified 199 common proteins. DAVID GO analysis identified monocarboxylate transporter 1 (MCT1) as a surface marker of SS-derived EVs, which was also highly expressed in SS patient-derived EVs compared with healthy individuals. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Thirty-four of 75 patients were treated with additive 5-FU based chemotherapy. OS was significantly prolonged in this patient subgroup (62 vs 57 months; p = 0.032). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: From January 2018 to January 2019, the clinical data of 16 patients who come from FuZhou, China underwent preoperative nano-carbon and titanium clip combined with robot-assisted laparoscopic transverse colon cancer surgery were retrospectively analyzed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The heat-killed LR used in this study contained 1 × 10(9) FU/g of LR in a commercial product. Pigs were fed each treatment for four weeks using a two-phase feeding program to measure growth performance and frequency of diarrhea. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This study investigates the effect of 5-fluorouracil (5-FU), irinotecan, and oxaliplatin (FOLFIRINOX), and gemcitabine plus nab-paclitaxel (GEMnPAC) regimens on PD-L1 mRNA expression in plasma-derived microvesicles (MVs) in 50 PDAC patients. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The intraperitoneally injected diHEP-DPA inhibited tumor growth when administered alone or in combination with 5-fluorouracil (5-FU) chemotherapy in vivo. We further found that diHEP-DPA effectively reversed TAM-conditioned medium (TCCM)-induced EMT and enhanced colorectal cancer stemness, as evidenced by its inhibition of colorectal cancer cell migration, invasion and expression of EMT markers, as well as cancer cell tumorspheres formation, without damaging colorectal cancer cells. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In vitro, RBM24 overexpression suppressed cell proliferation, migration, invasion and increased sensitivity to 5‐FU or cisplatin in CRC cells. Mechanistically, RBM24 maintained PTEN mRNA stability by directly binding to the GT‐rich region at positions 8101–8251 in the 3′‐UTR of PTEN mRNA, prolonging the half‐life of PTEN mRNA, thereby increasing PTEN expression. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso